Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Showing smoothed Capital Expenditure of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived, physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.
|Capital Expenditure||10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Edwards Lifesciences Capital Expenditure Over Time